Evidence map›Paper›PMID 40266347›Full record

ReviewCellular and molecular life sciences : CMLS2025

Multiple sclerosis: what have we learned and can we still learn from electron microscopy.

Wendy Oost, Jan F Meilof, Wia Baron

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wendy OostDepartment of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-7174-3168
Jan F MeilofDepartment of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-3827-7745
Wia BaronDepartment of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands. w.baron@umcg.nl.ORCID http://orcid.org/0000-0002-6673-4766

Funding

Stichting MS Research 18-733c
6 · The paper itself

Abstract

Multiple sclerosis (MS) is an inflammatory neurodegenerative disease marked by the formation of demyelinated lesions in the central nervous system. MS lesions can undergo remyelination, temporarily alleviating symptoms, but as the disease advances, remyelination becomes less effective. Beyond lesions, normal-appearing brain tissue exhibits subtle alterations, potentially indicating a broader, diffuse pathology and/or increased susceptibility to lesion formation. The pathology of MS varies between grey and white matter lesions and their normal-appearing regions, which most likely relates to their distinct cellular composition. Despite insights gained from MRI studies, serum and blood analyses, and post-mortem tissue examination, the molecular mechanisms driving MS lesion formation and persistent demyelination remain poorly understood. Exploring less conventional methods, such as electron microscopy (EM), may provide valuable new insights. EM offers detailed, nanometre-scale structural analysis that may enhance findings from immunohistochemistry and 'omics' approaches on MS brain tissue. Although earlier EM studies from before the 1990's provided some foundational data, advancements in EM technology now enable more comprehensive and detailed structural analysis. In this review we outline the pathogenesis of MS, summarize current knowledge of its ultrastructural features, and highlight how cutting-edge EM techniques could uncover new insights into pathological processes, including lesion formation, remyelination failure and diffuse pathology, which may aid therapeutic development.

Indexed as

Microscopy, ElectronMultiple SclerosisAnimalsBrainHumansMyelin SheathAxonBlood–brain barrierElectron microscopyMultiple sclerosisMyelinSynapse

Identifiers

PMID40266347
PMCPMC12018678

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.